Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01224509 · ClinicalTrials.gov registry record · NA
The Effect of Mifepristone on the Expression of Cervical Prostaglandin EP3 Receptors
A NA study, sponsored by University of Southern California.
- Terminated
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT01224509: Clinical Trial NA study, sponsored by University of Southern California.
NCT01224509 is a NA study that was terminated before completion, run by University of Southern California. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01224509, a NA study, was terminated before completion, sponsored by University of Southern California.
- TERMINATED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect of mifepristone on the expression of three cervical EP3 receptor isoforms (EP3-2, EP3-3 and EP3-6) in pregnant women ≤63 days gestational age.
Interventions
- DRUG Mifepristone
- OTHER Non-treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2004-09 |
| Est. Completion | 2005-03 |
| Phase | NA |
Why NCT01224509 stopped before completion
NCT01224509 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Mifepristone is the first listed.
NCT01224509 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01224509 about?
NCT01224509 is a clinical study titled "The Effect of Mifepristone on the Expression of Cervical Prostaglandin EP3 Receptors". The purpose of this study is to determine the effect of mifepristone on the expression of three cervical EP3 receptor isoforms (EP3-2, EP3-3 and EP3-6) in pregnant women ≤63 days gestational age.
What is the current status of trial NCT01224509?
This trial is currently terminated. It is a NA study. The enrollment target is 18 participants. The study started on 2004-09. Estimated completion is 2005-03.
What interventions are being tested in trial NCT01224509?
The interventions under investigation include: Mifepristone (DRUG), Non-treatment (OTHER).
Who is sponsoring clinical trial NCT01224509?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01224509's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia